Efficacy and influencing factors of percutaneous transhepatic cholangiography and biliary drainage in malignant obstructive jaundice patients.

IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
American journal of translational research Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI:10.62347/WXED3760
Haotian Wu, Xiang Xie
{"title":"Efficacy and influencing factors of percutaneous transhepatic cholangiography and biliary drainage in malignant obstructive jaundice patients.","authors":"Haotian Wu, Xiang Xie","doi":"10.62347/WXED3760","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To analyze the efficacy and influencing factors of percutaneous transhepatic cholangiography and biliary drainage (PTCD) in patients with malignant obstructive jaundice (MOJ).</p><p><strong>Methods: </strong>The study included 151 MOJ patients admitted from January 2021 to January 2024. Seventy patients in the control group received endoscopic retrograde cholangiopancreatography (ERCP), while 81 patients in the research group underwent PTCD. Clinical outcomes, including surgical success rate, efficacy (overall remission, high- and low-level intestinal obstruction remission), safety (bile leakage, septicemia, hemobilia, pancreatitis, and gastrointestinal bleeding), and clinical-related indicators (hospital stay, surgical cost, treatment cost), as well as serum biochemical markers (alanine aminotransferase [ALT], direct bilirubin [DBIL], and total bilirubin [TBIL]), were compared between the groups. Binary logistic regression was used to identify factors influencing PTCD efficacy.</p><p><strong>Results: </strong>The surgical success rate was significantly higher in the research group than that in the control group (P < 0.05). Although the overall remission rates were similar between the groups (P > 0.05), the research group had a lower low-level intestinal obstruction remission rate and a higher high-level intestinal obstruction remission rate (P < 0.05). Safety profiles and changes in pre- and post-operative serum biochemical markers did not differ significantly between the groups (all P > 0.05). The research group experienced longer hospital stays and lower surgical costs compared to the control group (both P < 0.05), while treatment costs were similar (P > 0.05). Binary logistic regression identified obstruction site, and preoperative liver dysfunction as factors influencing PTCD efficacy.</p><p><strong>Conclusions: </strong>PTCD demonstrated a higher surgical success rate than ERCP in MOJ patients, with comparable overall efficacy, safety, and treatment costs. PTCD was associated with longer hospital stays and lower surgical costs. Both procedures similarly improved ALT, DBIL, and TBIL levels. PTCD showed the greatest therapeutic benefit in cases of high-level intestinal obstruction.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"16 12","pages":"7725-7733"},"PeriodicalIF":1.7000,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733355/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of translational research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/WXED3760","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To analyze the efficacy and influencing factors of percutaneous transhepatic cholangiography and biliary drainage (PTCD) in patients with malignant obstructive jaundice (MOJ).

Methods: The study included 151 MOJ patients admitted from January 2021 to January 2024. Seventy patients in the control group received endoscopic retrograde cholangiopancreatography (ERCP), while 81 patients in the research group underwent PTCD. Clinical outcomes, including surgical success rate, efficacy (overall remission, high- and low-level intestinal obstruction remission), safety (bile leakage, septicemia, hemobilia, pancreatitis, and gastrointestinal bleeding), and clinical-related indicators (hospital stay, surgical cost, treatment cost), as well as serum biochemical markers (alanine aminotransferase [ALT], direct bilirubin [DBIL], and total bilirubin [TBIL]), were compared between the groups. Binary logistic regression was used to identify factors influencing PTCD efficacy.

Results: The surgical success rate was significantly higher in the research group than that in the control group (P < 0.05). Although the overall remission rates were similar between the groups (P > 0.05), the research group had a lower low-level intestinal obstruction remission rate and a higher high-level intestinal obstruction remission rate (P < 0.05). Safety profiles and changes in pre- and post-operative serum biochemical markers did not differ significantly between the groups (all P > 0.05). The research group experienced longer hospital stays and lower surgical costs compared to the control group (both P < 0.05), while treatment costs were similar (P > 0.05). Binary logistic regression identified obstruction site, and preoperative liver dysfunction as factors influencing PTCD efficacy.

Conclusions: PTCD demonstrated a higher surgical success rate than ERCP in MOJ patients, with comparable overall efficacy, safety, and treatment costs. PTCD was associated with longer hospital stays and lower surgical costs. Both procedures similarly improved ALT, DBIL, and TBIL levels. PTCD showed the greatest therapeutic benefit in cases of high-level intestinal obstruction.

恶性梗阻性黄疸经皮经肝胆道造影及胆道引流的疗效及影响因素。
目的:分析恶性梗阻性黄疸(MOJ)患者经皮经肝胆道造影及胆道引流术(PTCD)的疗效及影响因素。方法:研究纳入2021年1月至2024年1月收治的151例MOJ患者。对照组70例患者行内镜逆行胰胆管造影(ERCP),研究组81例患者行PTCD。比较两组患者的临床结局,包括手术成功率、疗效(总体缓解、高、低程度肠梗阻缓解)、安全性(胆漏、败血症、胆道出血、胰腺炎、胃肠道出血)、临床相关指标(住院时间、手术费用、治疗费用)以及血清生化指标(丙氨酸转氨酶[ALT]、直接胆红素[DBIL]、总胆红素[TBIL])。采用二元logistic回归分析影响PTCD疗效的因素。结果:研究组手术成功率明显高于对照组(P < 0.05)。虽然两组间总体缓解率相似(P < 0.05),但研究组低水平肠梗阻缓解率较低,高水平肠梗阻缓解率较高(P < 0.05)。两组患者的安全性及术前、术后血清生化指标变化无显著差异(P < 0.05)。与对照组相比,研究组住院时间更长,手术费用更低(P < 0.05),治疗费用相似(P < 0.05)。二元logistic回归分析发现梗阻部位和术前肝功能障碍是影响PTCD疗效的因素。结论:在MOJ患者中,PTCD的手术成功率高于ERCP,两者的总体疗效、安全性和治疗成本相当。PTCD与较长的住院时间和较低的手术费用有关。两种方法均可改善ALT、DBIL和TBIL水平。PTCD在高位肠梗阻中显示出最大的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of translational research
American journal of translational research ONCOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
自引率
0.00%
发文量
552
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信